How Do I Decide to Treat Patients with Geographic Atrophy?

Related

• 

  Use of Ellipsoid Zone Analysis As an Efficacy Endpoint in Clinical Trials for Geographic Atrophy

  Peter K. Kaiser, MD FASRS

  Annual Meeting Talks

  2023

• 

  Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study

  Priyatham (Prithu) S Mettu, MD

  Updates from the Field

  2019

• 

  Expert Panel: AI

  Mark S. Humayun, MD, PhD

  Devinder S Chauhan, MD FRCOphth FRANZCO

  Ursula M. Schmidt-Erfurth, MD

  Jennifer I. Lim, MD, FARVO, FASRS

  Royce WS Chen, MD

  Annual Meeting Talks

  2024